1. Home
  2. ACAD vs CAKE Comparison

ACAD vs CAKE Comparison

Compare ACAD & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$25.58

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo Cheesecake Factory Incorporated (The)

CAKE

Cheesecake Factory Incorporated (The)

HOLD

Current Price

$85.43

Market Cap

3.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACAD
CAKE
Founded
1993
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.5B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
ACAD
CAKE
Price
$25.58
$85.43
Analyst Decision
Buy
Hold
Analyst Count
22
16
Target Price
$30.55
$60.31
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
1.92%
EPS Growth
69.12
N/A
EPS
0.02
1.02
Revenue
$726,437,000.00
$3,751,806,000.00
Revenue This Year
$18.80
$6.14
Revenue Next Year
$11.70
$6.65
P/E Ratio
$1,282.50
$81.90
Revenue Growth
40.45
4.75
52 Week Low
$19.69
$43.07
52 Week High
$28.35
$84.54

Technical Indicators

Market Signals
Indicator
ACAD
CAKE
Relative Strength Index (RSI) 62.29 72.08
Support Level $25.40 $56.82
Resistance Level $27.79 N/A
Average True Range (ATR) 0.80 2.83
MACD -0.08 0.06
Stochastic Oscillator 40.63 88.44

Price Performance

Historical Comparison
ACAD
CAKE

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

About CAKE Cheesecake Factory Incorporated (The)

The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.

Share on Social Networks: